Products and Services
-
Phillips Medisize, which completed its acquisition of inhalation CDMO Vectura in 2025, has announced the acquisition of all remaining portions of the former Vectura site in Chippenham, UK. The acquisition of Vectura originally included only… Read more . . .
-
Cambridge Healthcare Innovations announced that its Quattrii blister-based DPI has been selected for delivery of inhaled dry powder formulations of biologics being developed by University College London professor Jenny Lam. CHI partnered with Aptar in… Read more . . .
-
1nhaler raises additional £2.2 million for development of its single-dose salbutamol (albuterol) DPI
1nhaler announced that it has closed a £2.2 million funding round led by Archangels, with the proceeds intended to support preparations for a clinical trial of its disposable, single-dose 1nhaler Salbutamol DPI with a goal… Read more . . .
-
Aptar Pharma announced that it has acquired Pulmotree, the developer of the Kolibri mesh nebulizer, which it refers to as a non-propellant liquid inhaler. The Kolibri nebulizer is a breath-activated, connected device that provides real-time… Read more . . .
-
Aptar Pharma’s LuerVax single-use nasal vaccine delivery device is now CE marked, the company announced. An optional accessory that allows for division of the vaccine so that half of the dose can be sprayed into… Read more . . .
-
Aptar Pharma has announced the addition of molding capabilities to its OINDP manufacturing facility in Mumbai, India, which was opened in 2023. Products produced at the plant include MDI valves, breath-actuated inhalers, and nasal delivery devices.… Read more . . .
-
CDMO Bespak, which recently said that it had partnered with Upperton to offer nasal drug/device development and manufacturing and launched a new soft mist intranasal delivery device, has announced that it will now offer access… Read more . . .
-
CDMO Bespak, which recently announced a collaboration with Upperton to offer complete nasal drug/device development and manufacturing services, has now announced the launch of a new soft mist nasal delivery device called NasaDose Ultra Soft Unit… Read more . . .
-
Harro Höfliger says that dry-filling technology for metered dose inhaler production, which has previously been available only at laboratory scale, is now available for commercial scale production lines. Dry filling, which Harro has developed in… Read more . . .
-
Aptar Pharma has announced that its Orbital high-payload dry powder inhaler will be key to a Macquarie University research project titled “Unlocking the Potential of Dry Powder Carriers for Biologic Applications” which is funded by a… Read more . . .
Upcoming Events
Sponsored by Intertek
Want information about upcoming OINDP-related events delivered directly to your inbox? click here
December 9-December 11: DDL 2026, Edinburgh, Scotland
April 27-30: RDD Europe 2027, Antibes, France
May 12-13: USP Joint Workshop: Quality and Product Performance Testing of Orally Inhaled and Nasal Drug Products, Rockville, MD, USA
June 30: RespireX 2027, Boston, MA, USA